RecruitingNot Applicable

REBOA in Nontraumatic OHCA

South Korea234 participantsStarted 2023-10-17

Plain-language summary

The investigators propose a multicenter randomized controlled trial in South Korea and Taiwan to observe the clinical effects of REBOA on nontraumatic out-of-hospital-cardiac-arrest (OHCA) patients. While REBOA has been traditionally used in trauma for hemorrhage control, it has also shown promising results in nontraumatic cardiac arrests by rerouting circulation to increase perfusion in the coronary and brain.

Who can participate

Age range20 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Exclusion criteria

✕. age below 20 years old or over 80 years old,
✕. traumatic cardiac arrest,
✕. those with unwitnessed cardiac arrest,
✕. pregnant patients,
✕. patients who have already achieved ROSC upon arrival at the emergency department
✕. pre-cardiac arrest cerebral performance category of 3-4
✕. those showing evidence of cardiac arrest due to bleeding (such as gastrointestinal bleeding)
✕. those suspected of having aortic disease, such as dissection, intramural hematoma, or aneurysm, by bedside ultrasound performed immediately after ED arrival or have a previous history of aortic disease

What they're measuring

Number of Participants Who Achieved ROSC (return of spontaneous circulation)

Timeframe: 24 hours

Trial details

NCT IDNCT06031623

SponsorSeoul National University Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-10-01

Contact for this trial

Hee Eun Kim

82-31-787-7579 hekim9111@gmail.com

View on ClinicalTrials.gov More Cardiopulmonary Arrest trials